Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Herta M. Crauwels

Pharmacokinetics, Antiviral Activity, and Safety of Rilpivirine in Pregnant Women With HIV-1 Infection: Results of a Phase 3b, Multicenter, Open-Label Study

Infectious Diseases and Therapy
Infectious DiseasesMicrobiology
2018English

Related publications

Efficacy, Safety and Pharmacokinetics of Subcutaneous Azacitidine in Chinese Patients With Higher Risk Myelodysplastic Syndromes: Results From a Multicenter, Single-Arm, Open-Label Phase 2 Study

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2017English

Pharmacokinetics and Safety of Apremilast in Pediatric Patients With Moderate to Severe Plaque Psoriasis: Results From a Phase 2 Open-Label Study

Journal of the American Academy of Dermatology
Dermatology
2020English

Antiviral Activity, Safety, and Pharmacokinetics of Bictegravir as 10-Day Monotherapy in HIV-1–Infected Adults

Journal of Acquired Immune Deficiency Syndromes
Infectious DiseasesPharmacology
2017English

A Phase 1 Open -Label Multicenter Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Calcipotriene Foam, 0.005% Applied Under Maximal Use Conditions in Adolescent Subjects With Plaque Psoriasis

SKIN The Journal of Cutaneous Medicine
2019English

Population Pharmacokinetics of Nevirapine in HIV-1-Infected Pregnant Women and Their Neonates

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2010English

Population Pharmacokinetics and Pharmacogenetics Analysis of Rilpivirine in HIV-1-Infected Individuals

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2016English

Population Pharmacokinetics of Artesunate and Dihydroartemisinin in Pregnant and Non-Pregnant Women With Uncomplicated Plasmodium Falciparum Malaria in Burkina Faso: An Open Label Trial

Wellcome Open Research
BiochemistryMedicineGeneticsMolecular Biology
2019English

Umbralisib Monotherapy Demonstrates Efficacy and Safety in Patients With Relapsed/Refractory Marginal Zone Lymphoma: A Multicenter, Open-Label, Registration Directed Phase 2 Study

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Efficacy, Safety and Population Pharmacokinetics of Sapropterin in PKU Patients <4 Years: Results From the SPARK Open-Label, Multicentre, Randomized Phase IIIb Trial

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy